作者
Bo Shen,Gursimran Kochhar,Udayakumar Navaneethan,Raymond K. Cross,Francis A. Farraye,Marietta Iacucci,David A. Schwartz,Yago González‐Lama,Jason Schairer,Ravi P. Kiran,Paulo Gustavo Kotze,Taku Kobayashi,Martin Bortlík,Xiuli Liu,Alexander N. Levy,Begoña González-Suárez,Shou–jiang Tang,Nayantara Coelho‐Prabhu,Martin Lukáš,David H. Bruining,Sandra El‐Hachem,Roger J. Charles,Yan Chen,Ajit Sood,Ren Mao,Carme Loras,Parambir S. Dulai,Joseph A. Picoraro,Michael Chiorean,Milan Lukáš,Amandeep K. Shergill,Mark S. Silverberg,William J. Sandborn,Çharles N. Bernstein
摘要
The majority of patients with Crohn's disease and a proportion of patients with ulcerative colitis will ultimately require surgical treatment despite advances in diagnosis, therapy, and endoscopic interventions. The surgical procedures that are most commonly done include bowel resection with anastomosis, strictureplasty, faecal diversion, and ileal pouch. These surgical treatment modalities result in substantial alterations in bowel anatomy. In patients with inflammatory bowel disease, endoscopy plays a key role in the assessment of disease activity, disease recurrence, treatment response, dysplasia surveillance, and delivery of endoscopic therapy. Endoscopic evaluation and management of surgically altered bowel can be challenging. This consensus guideline delineates anatomical landmarks and endoscopic assessment of these landmarks in diseased and surgically altered bowel.